Join the Rifaximin group to help and get support from people like you.
Rifaximin News
Rates of Tx Retention for Rifaximin Low Despite Benefits for Hepatic Encephalopathy
FRIDAY, Sept. 1, 2023 – Rates of rifaximin treatment retention are low despite the known benefits of rifaximin use for breakthrough hepatic encephalopathy (HE), according to a study published in the...
FDA Approves Xifaxan (rifaximin) for the Treatment of IBS-D (Irritable Bowel Syndrome with Diarrhea)
LAVAL, Quebec, May 27, 2015 /PRNewswire/ – Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) announced that its wholly owned subsidiary, Salix Pharmaceuticals, Inc., has received...
FDA Approves New Use of Xifaxan for Patients with Liver Disease
SILVER SPRING, Md., March 24 /PRNewswire-USNewswire/ – The U.S. Food and Drug Administration today approved the use of Xifaxan for reduction in the risk of the recurrence of overt hepatic...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Irritable Bowel Syndrome, Crohn's Disease, Diarrhea